Finally, the study found that upregulating mutations in YTHDF1 and HNRNPA2B1 correlated with tumor stage and treatment response in patients, further supporting their roles, asm6A regulatory genes, in melanoma. This evidence concerns the gene YTHDF1 and melanoma.